PhRMA, GPhA Back Plan to Exempt Fees from Sequestration
Plans to make fees drugmakers pay the US FDA in future exempt from mandatory Government spending cuts have been welcomed by industry groups.
Archives for July 28, 2013
Lumora Licenses Promega Marker and Eyes Diagnostics Tech Hungry CROs
Lumora has added a novel marker to its diagnostics platform in a deal with reagent supplier Promega and says CROs are a potential market.
Update
CROs Press for More Adaptive Trials and Predict Surge in Demand
Risk-averse sponsors are still slow to seek adaptive trial designs, but CROs building expertise in the field expect demand to increase.
Icon Q2 Revenue Up as Early Phase Work Continues to Slow
Top customers generated a greater proportion of Icon's revenue in Q2, while demand for early phase development work continued to slow.
$85m Plant Demonstrates Russia's Commitment to Pharma 2020, says NovaMedica
NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.